Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects
Clinical trial NCT03928353 · COMPLETED
Trial details
- NCT number
- NCT03928353
- Sponsor
- SFJ Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2019-10-09
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.